A stable liver-specific urate oxidase gene knockout hyperuricemia mouse model finds activated hepatic de novo purine biosynthesis and urate nephropathy

Lei Pang,Ningning Liang,Changgui Li,Tony R Merriman,Hui Zhang,Fei Yan,Wenyan Sun,Rui Li,Xiaomei Xue,Zhen Liu,Can Wang,Xiaoyu Cheng,Shiting Chen,Huiyong Yin,Nicola Dalbeth,Xuan Yuan,Tony R. Merriman
DOI: https://doi.org/10.1016/j.bbadis.2023.167009
IF: 6.633
2024-03-01
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Abstract:Urate oxidase (Uox)-deficient mice could be an optimal animal model to study hyperuricemia and associated disorders. We develop a liver-specific conditional knockout Uox-deficient (Uox<sup>CKO</sup>) mouse using the Cre/loxP gene targeting system. These Uox<sup>CKO</sup> mice spontaneously developed hyperuricemia with accumulated serum urate metabolites. Blocking urate degradation, the Uox<sup>CKO</sup> mice showed significant de novo purine biosynthesis (DNPB) in the liver along with amidophosphoribosyltransferase (Ppat). Pegloticase and allopurinol reversed the elevated serum urate (SU) levels in Uox<sup>CKO</sup> mice and suppressed the Ppat up-regulation. Although urate nephropathy occurred in 30-week-old Uox<sup>CKO</sup> mice, 90 % of Uox-deficient mice had a normal lifespan without pronounced urate transport abnormality. Thus, Uox<sup>CKO</sup> mice are a stable model of human hyperuricemia. Activated DNPB in the Uox<sup>CKO</sup> mice provides new insights into hyperuricemia, suggesting increased SU influences purine synthesis.
biochemistry & molecular biology,biophysics
What problem does this paper attempt to address?